Christophe Klein

Christophe Klein

Auto-generated profile, based on publicly available information

Christophe Klein

Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2018 in Science
Verified
Journal Article
Closed access
PDF file
BRBertrand Routy
Bertrand Routy
ECEmmanuelle Le Chatelier
Emmanuelle Le Chatelier
LDLisa Derosa
Lisa Derosa
CDConnie P. M. Duong
Connie P. M. Duong
MAMaryam Tidjani Alou
Maryam Tidjani Alou
LZLaurence Zitvogel
Laurence Zitvogel
Good bacteria help fight cancer: Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila . Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science , this issue p. 91 , p. 104 , p. 97 ; see also p. 32

1 February 2014 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JGJérémy Goc
Jérémy Goc
CGClaire Germain
Claire Germain
TVThi Kim Duy Vo-Bourgais
Thi Kim Duy Vo-Bourgais
ALAudrey Lupo
Audrey Lupo
CKChristophe Klein
Christophe Klein
MDMarie-Caroline Dieu-Nosjean
Marie-Caroline Dieu-Nosjean
Tumor-infiltrating T cells, particularly CD45RO+CD8+ memory T cells, confer a positive prognostic value in human cancers. However, the mechanisms that promote a protective T-cell response in the tumor microenvironment remain unclear. In chronic inflammatory settings such as the tumor microenvironment, lymphoid neogenesis can occur to create local lymph node–like structures known as tertiary lymphoid structures (TLS). These structures can exacerbate a local immune response, such that TLS formation in tumors may help promote an efficacious immune contexture. However, the role of TLS in tumors has yet to be investigated carefully. In lung tumors, mature dendritic cells (DC) present in tumor-associated TLS can provide a specific marker of these structures. In this study, we evaluated the influence of TLS on the characteristics of the immune infiltrate in cohorts of prospective and retrospective human primary lung tumors (n = 458). We found that a high density of mature DC correlated closely to a strong infiltration of T cells that are predominantly of the effector–memory phenotype. Moreover, mature DC density correlated with expression of genes related to T-cell activation, T-helper 1 (Th1) phenotype, and cytotoxic orientation. Lastly, a high density of TLS-associated DC correlated with long-term survival, which also allowed a distinction of patients with high CD8+ T-cell infiltration but a high risk of death. Taken together, our results show how tumors infiltrated by TLS-associated mature DC generate a specific immune contexture characterized by a strong Th1 and cytotoxic orientation that confers the lowest risk of death. Furthermore, our findings highlight the pivotal function of TLS in shaping the immune character of the tumor microenvironment, in promoting a protective immune response mediated by T cells against cancer. Cancer Res; 74(3); 705–15. ©2013 AACR.

15 January 2006 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CBCécIle Badoual
CécIle Badoual
SHStépHane Hans
StépHane Hans
JRJosé Rodriguez
José Rodriguez
SPSeverine Peyrard
Severine Peyrard
CKChristophe Klein
Christophe Klein
Eric TartourEric Tartour
Eric Tartour
Purpose: CD4+ T cells play a central role in initiating and maintaining anticancer immune responses. However, regulatory CD4+CD25+ T cells which express Foxp3 have also been shown to inhibit antitumor effector T cells. In view of these heterogeneous CD4+ T-cell populations, this study was designed to determine the prognostic value of various tumor-infiltrating CD4+ T-cell populations in head and neck squamous cell carcinoma. Experimental Design: Eighty-four newly diagnosed untreated patients with histologically proven primary head and neck squamous cell carcinoma were included in this study. Double or triple immunofluorescence staining was done to assess and quantify the activated CD4+CD69+ T cells, regulatory CD4+Foxp3+ T cells, and mixed CD4+CD25+ T cells comprising both activated and regulatory T cells. Results: On univariate analysis, high levels of tumor-infiltrating CD4+CD69+ T cells were correlated with both better locoregional control (P = 0.01) and longer survival (P = 0.01). Infiltration by regulatory Foxp3+CD4+ T cells was positively associated with a better locoregional control of the tumor. Multivariate analysis showed that the only significant prognostic factors related to locoregional control were T stage (P = 0.02) and CD4+Foxp3+ T-cell infiltration of the tumor (P = 0.02). In the Cox multivariate analysis, only two variables influenced overall survival probability: T stage (P = 0.036) and CD4+CD69+ T-cell infiltration (P = 0.017). Conclusion: This study shows that tumor-infiltrating activated CD4+CD69+ T cells are associated with a good prognosis in head and neck squamous cell carcinoma. In addition, regulatory Foxp3+CD4+ T cells are positively correlated with locoregional control may be through down-regulation of harmful inflammatory reaction, which could favor tumor progression.

3 September 2019 in Cell Research
Verified
Journal Article
Open access
PDF file
NJNicolas Jacquelot
Nicolas Jacquelot
TYTakahiro Yamazaki
Takahiro Yamazaki
MRMaria P. Roberti
Maria P. Roberti
CDConnie P. M. Duong
Connie P. M. Duong
MAMiles C. Andrews
Miles C. Andrews
LZLaurence Zitvogel
Laurence Zitvogel
PD-1 blockade represents a major therapeutic avenue in anticancer immunotherapy. Delineating mechanisms of secondary resistance to this strategy is increasingly important. Here, we identified the deleterious role of signaling via the type I interferon (IFN) receptor in tumor and antigen presenting cells, that induced the expression of nitric oxide synthase 2 (NOS2), associated with intratumor accumulation of regulatory T cells (Treg) and myeloid cells and acquired resistance to anti-PD-1 monoclonal antibody (mAb). Sustained IFNβ transcription was observed in resistant tumors, in turn inducing PD-L1 and NOS2 expression in both tumor and dendritic cells (DC). Whereas PD-L1 was not involved in secondary resistance to anti-PD-1 mAb, pharmacological or genetic inhibition of NOS2 maintained long-term control of tumors by PD-1 blockade, through reduction of Treg and DC activation. Resistance to immunotherapies, including anti-PD-1 mAb in melanoma patients, was also correlated with the induction of a type I IFN signature. Hence, the role of type I IFN in response to PD-1 blockade should be revisited as sustained type I IFN signaling may contribute to resistance to therapy.

25 May 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MRMaria Paula Roberti
Maria Paula Roberti
SYSatoru Yonekura
Satoru Yonekura
CDConnie P. M. Duong
Connie P. M. Duong
MPMarion Picard
Marion Picard
GFGladys Ferrere
Gladys Ferrere
LZLaurence Zitvogel
Laurence Zitvogel

1 November 2003 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
FGF. Gouyon
F. Gouyon
LCL. Caillaud
L. Caillaud
Véronique CarrièreVéronique Carrière
Véronique Carrière
CKC. Klein
C. Klein
VDV. Dalet
V. Dalet
EBE. Brot‐Laroche
E. Brot‐Laroche
The physiological significance of the presence of GLUT2 at the food‐facing pole of intestinal cells is addressed by a study of fructose absorption in GLUT2‐null and control mice submitted to different sugar diets. Confocal microscopy localization, protein and mRNA abundance, as well as tissue and membrane vesicle uptakes of fructose were assayed. GLUT2 was located in the basolateral membrane of mice fed a meal devoid of sugar or containing complex carbohydrates. In addition, the ingestion of a simple sugar meal promoted the massive recruitment of GLUT2 to the food‐facing membrane. Fructose uptake in brush‐border membrane vesicles from GLUT2‐null mice was half that of wild‐type mice and was similar to the cytochalasin B‐insensitive component, i.e. GLUT5‐mediated uptake. A 5 day consumption of sugar‐rich diets increased fructose uptake fivefold in wild‐type tissue rings when it only doubled in GLUT2‐null tissue. GLUT5 was estimated to contribute to 100 % of total uptake in wild‐type mice fed low‐sugar diets, falling to 60 and 40 % with glucose and fructose diets respectively; the complement was ensured by GLUT2 activity. The results indicate that basal sugar uptake is mediated by the resident food‐facing SGLT1 and GLUT5 transporters, whose mRNA abundances double in long‐term dietary adaptation. We also observe that a large improvement of intestinal absorption is promoted by the transient recruitment of food‐facing GLUT2, induced by the ingestion of a simple‐sugar meal. Thus, GLUT2 and GLUT5 could exert complementary roles in adapting the absorption capacity of the intestine to occasional or repeated loads of dietary sugars.